相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
Jung-Fu Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETOLOGIA (2020)
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)
Neda Laiteerapong et al.
DIABETES CARE (2019)
Standards of medical care for type 2 diabetes in China 2019
Weiping Jia et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
David R. Matthews et al.
LANCET (2019)
Efficacy and tolerability of exenatide once weekly over 7 years in patients with type 2 diabetes: An open-label extension of the DURATION-1 study
Athena Philis-Tsimikas et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
Tamara Y. Milder et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes
Ken Lee Chin et al.
SCIENTIFIC REPORTS (2019)
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
Sachin Khunti et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Mee Kyoung Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis
B. M. Mishriky et al.
DIABETES & METABOLISM (2018)
Japanese Clinical Practice Guideline for Diabetes 2016
Masakazu Haneda et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
Nam Hoon Kim et al.
BMJ OPEN (2018)
Efficacy and Safety of Initial Combination Therapy in Treatment-Na⟨ve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis
Xiaoling Cai et al.
DIABETES THERAPY (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach
Eugenio Cersosimo et al.
DIABETES OBESITY & METABOLISM (2018)
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
Zhiying Wang et al.
DIABETES OBESITY & METABOLISM (2018)
Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus A meta-analysis
Jian Li et al.
MEDICINE (2017)
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes A Systematic Review and Meta-analysis
Nisa M. Maruthur et al.
ANNALS OF INTERNAL MEDICINE (2016)
Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
Avivit Cahn et al.
DIABETES CARE (2016)
Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
Lana Pinto et al.
Diabetology & Metabolic Syndrome (2015)
Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis
D. Wu et al.
DIABETES OBESITY & METABOLISM (2014)
Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
O. J. Phung et al.
DIABETES OBESITY & METABOLISM (2014)
Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review
Silvio E. Inzucchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Introduction
Alice Y. Y. Cheng
CANADIAN JOURNAL OF DIABETES (2013)
Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
David M. Nathan et al.
DIABETES CARE (2013)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
